Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Leora Horn, Aaron S. Mansfield, Aleksandra Szczęsna et al. · New England Journal of Medicine · 2018 · 3.3K citations · Full text

Comprehensive genomic profiles of small cell lung cancer

Julie George, Jing Lim, Se Jin Jang et al. · Nature · 2015 · 2.3K citations · Full text

Cancer Genomics, Bronchial Neoplasm, Comprehensive Genomic Profiles +3

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Establishment and identification of small cell lung cancer cell lines having classic and variant features

Desmond N. Carney, Adi F. Gazdar, Gerold Bepler et al. · Lung Cancer · 1986 · 912 citations

Tumor Biology, Tumor Heterogeneity, Medicine +11

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park et al. · Cancer Cell · 2021 · 864 citations · Full text

Immunogenetics, Systems Biology, Distinct Therapeutic Vulnerabilities +11